Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Enanta Pharmaceuticals (ENTA) over the last 4 years, with Q2 2015 value amounting to $2000.0.

  • Enanta Pharmaceuticals' Treasury Shares changed 0.0% to $2000.0 in Q2 2015 from the same period last year, while for Jun 2015 it was $2000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2000.0 for FY2014, which is 0.0% changed from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Treasury Shares stood at $408000.0 for Q3 2025, which was down 467.29% from $414000.0 recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Treasury Shares high stood at $455000.0 for Q4 2023, and its period low was $117000.0 during Q3 2021.
  • In the last 5 years, Enanta Pharmaceuticals' Treasury Shares had a median value of $414000.0 in 2025 and averaged $335368.4.
  • Within the past 5 years, the most significant YoY rise in Enanta Pharmaceuticals' Treasury Shares was 0.0% (2013), while the steepest drop was 0.0% (2013).
  • Over the past 4 years, Enanta Pharmaceuticals' Treasury Shares (Quarter) stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
  • Its Treasury Shares stands at $2000.0 for Q2 2015, versus $2000.0 for Q1 2015 and $2000.0 for Q4 2014.